Amphiphilic kanamycin derivatives, such as KI07, offer a novel antifungal solution with a unique mode of action, broad-spectrum efficacy, and low animal toxicity. Ideal for agricultural use, they provide an alternative to azole-based fungicides with no fungal resistance observed.
Amphiphilic kanamycin derivatives, particularly KI07, represent a breakthrough in antifungal technology by offering a novel mechanism that disrupts fungal cell membranes, leading to cell death. Unlike traditional azole-based fungicides, these derivatives show no development of fungal resistance, making them a promising alternative. Leveraging naturally occurring kanamycin and fatty acids, these compounds demonstrate broad-spectrum fungicidal activity with minimal animal toxicity, positioning them as a viable option for agricultural applications, including seed-coating to protect crops from pathogens.
Key features:
The preparation process for these compounds is efficient, involving short steps that are scalable for mass production, ensuring cost-effectiveness in industrial applications.
Currently, the technology is at TRL 4, having been validated in laboratory settings. Further validation efforts are underway, focusing on the effectiveness of these derivatives in treating specific plant diseases, such as soybean sudden death syndrome. The research team is actively seeking partners for licensing and manufacturing, as well as sponsors for further research development.
Utah State University is a comprehensive public land‑grant research university (Carnegie R1) serving Utah through a flagship Logan campus and a statewide network. Industry connects through the Innovation Campus research park, where companies co‑locate with faculty and access shared facilities. USU’s Space Dynamics Laboratory, a US Space Force–sponsored University Affiliated Research Center, offers mission‑driven pathways for space and defense collaboration. Statewide Extension offices and field sites enable pilot deployments and real‑world validation across Utah’s diverse settings. Research is supported by competitive federal funding from agencies such as NSF, USDA, NASA, and DoD, with Technology Transfer Services managing IP, licensing, and SBIR/STTR support.